Fundamental analysis of Dasoeh shares / profit forecast for 1402 of Dasoeh Pharmaceuticals – Tejaratnews

According to Tejarat News, a look at the status of Eswe Pharmaceutical Company shows that the company was able to increase its sales in addition to the production amount until 1402. The same upward trend in the company’s production and sales caused the increase in profitability at the end of Dasoeh’s financial year to be expected.

value of producations

To prove this, it is enough to add the production and sales figures of the first four monthly reports of the two years 1401 and 1402. First, the numbers of production values ​​are examined. The total amount of the company’s production in the first four months of 1402 is more than 204 million and 248 thousand pieces, which has increased by about 32% compared to the production of 154 million and 581 thousand pieces in the first four months of 1401.

Of course, regarding the amount of production of the company, it should be said that until the first three months, Dasoeh had maintained its production amount on an upward trend, and this trend was stopped in July. Because the company’s production in July has decreased by 14% compared to June. It should be mentioned that if the upward trend of the company’s production continued in July, the company would have registered a better four-month period.

sales amount

This also applies to the amount of sales of the company. So that the company was able to sell 197 million and 343 thousand units of its products in the first four months of this year, which was 163 million and 12 thousand units last year.

Of course, in July, the company’s performance in sales was not good, and the company’s sales amount decreased from 72 million 603 thousand to 46 million 290 thousand with a decrease of 36%.

Earnings

The growth of the company’s sales in the four months of this year caused the income of Osweh Pharmaceuticals to increase significantly during this period. So that the company’s income increased from 183 billion Tomans in the first four months of last year to 368 billion Tomans in the first four months of this year.

Of course, the growth of the company’s income was not only due to the growth of the sales volume, and the sales rate of the company’s products also increased significantly during this period. So that the sales rates of Osweh Pharmaceutical Company have increased by more than 66% during this period.

Even though the company’s production and sales figures in July faced a noticeable drop compared to June, but overall, Dasoeh’s performance in the first four months was acceptable. So that according to the current values, the net profit of the company is expected to increase by 20% at the end of 2012.

Read more reports on the capital market page.